Medtronic initiates u.s. ide clinical study evaluating hugo™ robotic-assisted surgery system for gynecological procedures

First procedures completed and enrollment underway in embrace gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the united states galway, ireland , oct. 8, 2025 /prnewswire/ -- medtronic plc (nyse: mdt) today announced the start of the embrace gynecology investigational device exemption (ide) u.s. clinical study to evaluate the safety and effectiveness of its hugo™ robotic-assisted surgery (ras) system in robotic-assisted gynecological procedures. the first procedures, total hysterectomies, were successfully completed at ahn west penn hospital in pittsburgh, pa, by dr. sarah crafton and dr. eirwen miller, embrace gynecology study surgeons at allegheny health network.
MDT Ratings Summary
MDT Quant Ranking